共 50 条
- [41] Discovery of MK-1468: A Potent, Kinome-Selective, Brain-Penetrant Amidoisoquinoline LRRK2 Inhibitor for the Potential Treatment of Parkinson's DiseaseJOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (21) : 14912 - 14927Kattar, Solomon D.Gulati, AnmolMargrey, Kaila A.Keylor, Mitchell H.Ardolino, MichaelYan, XinJohnson, RebeccaPalte, Rachel L.McMinn, Spencer E.Nogle, LisaSu, JingXiao, DongPiesvaux, JenniferLee, SusiHegde, Laxminarayan G.Woodhouse, Janice D.Faltus, RobertMoy, Lily Y.Xiong, TinaCiaccio, Paul J.Pearson, KaraPatel, MayankbhaiOtte, Karin M.Leyns, Cheryl E. G.Kennedy, Matthew E.Bennett, David JonathanDimauro, Erin F.Fell, Matthew J.Fuller, Peter H.
- [42] Design, synthesis, and evaluation of genipin derivatives for the treatment of Alzheimer's DiseaseCHEMICAL BIOLOGY & DRUG DESIGN, 2019, 93 (02) : 110 - 122Huang, WeijunWang, YujunLi, JiamingZhang, YanchunMa, XiaodongZhu, PanhuZhang, Yang
- [43] Design and synthesis of a potent, selective CCR2 receptor antagonist as a potential treatment for atherosclerosisABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 239Wang, Gren Z.Zhang, JingViet, Andrew Q.Haile, Pamela A.Goodman, Krista B.Dowdell, Sarah E.Sha, DeyouDaniel, ThomasHughes, Terry V.Miller, Nathan A.Miskowski, Tamara A.Eidam, Hilary S.Fox, Ryan M.Lee, DennisEvans, ChristopherGough, PeterSehon, Clark A.
- [44] Synthesis design of 'Rivastigmine'-a potent therapeutic agent for Alzheimer's disease using retrosynthetic analysisJ. Chem. Pharm. Res., 1600, 6 (3171-3183):Department of Chemistry, Utkal University, Bhubaneswar-751004, Odisha, India
- [45] Tau pathology reduction with SM07883, a novel, potent, and selective oral DYRK1A inhibitor: A potential therapeutic for Alzheimer's diseaseAGING CELL, 2019, 18 (05)Melchior, BenoitMittapalli, Gopi KumarLai, CarolynDuong-Polk, KarenStewart, JoshuaGuner, BoraHofilena, BrianTjitro, AmandaAnderson, Scott D.Herman, David S.Dellamary, LuisSwearingen, Christopher J.Sunil, K. C.Yazici, Yusuf
- [46] Design and synthesis of potential inhibitors of multienzyme systems included in Alzheimer's diseaseBULGARIAN CHEMICAL COMMUNICATIONS, 2015, 47 (02): : 531 - 534Ivanov, I.Vezenkov, L.Danalev, D.
- [47] Discovery of AZD3839, a Potent and Selective BACE1 Inhibitor Clinical Candidate for the Treatment of Alzheimer DiseaseJOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (49) : 41245 - 41257Jeppsson, FredrikEketjall, SusannaJanson, JulietteKarlstrom, SofiaGustavsson, SusanneOlsson, Lise-LotteRadesater, Ann-CathrinePloeger, BartCebers, GvidoKolmodin, KarinSwahn, Britt-Marievon Berg, StefanBueters, TjerkFalting, Johanna
- [49] A clinical trial of rofecoxib, a selective COX-2 inhibitor, for the treatment of Alzheimer's diseaseNEUROBIOLOGY OF AGING, 2002, 23 (01) : S73 - S74Block, GNorman, BLiu, GLines, CReines, SMorris, J
- [50] Design, synthesis and biological evaluation of naringenin carbamate derivatives as potential multifunctional agents for the treatment of Alzheimer's diseaseBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 49Wu, JiaruiKou, XiaodiJu, HuiZhang, HongweiYang, AihongShen, Rui